Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials by Vale, C, Godolphin, PJ, Fisher, D, Horby, PW, Kosiborod, MN, Hochman, JS, Webster, K, Higgins, JPT, Althouse, AD, Berwanger, O, Furtado, RHM, Gasparyan, SB, Haynes, R, Koch, GG, Landray, M, Leifer, E, Marshall, J, Murthy, S, Neal , M, Staplin, N, Diaz, J, Sterne, JAC, Shankar-Hari, M